Jasper Therapeutics, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Jasper Therapeutics, Inc. now
Current reporting with the operating signal separated from the noise.
JSPRW Jasper Therapeutics, Inc. WT EXP 092426
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Jasper Therapeutics, Inc. Announces Merger with Kira Pharmaceuticals
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Jasper Therapeutics, Inc.: Jasper Therapeutics Announces Exploration of Strategic Alternatives to Maximize Shareholder Value
Investors are testing whether Jasper Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Law Offices of Howard G. Smith Encourages Jasper Therapeutics, Inc. (JSPR) Investors To Inquire About Securities Fraud Class Action
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Jasper Therapeutics, Inc. Sued for Securities Law Violations
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Jasper Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Jasper Therapeutics, Inc. Announces Reverse Stock Split
Investors are testing whether Jasper Therapeutics, Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.All You Need to Know About Jasper Therapeutics, Inc. (JSPR) Rating Upgrade to Buy
The story matters when it changes Jasper Therapeutics, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest JSPR filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Jasper Therapeutics, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →